Xiang Z, Ma B, Pei X, Wang W, Gong W
Pharm Biol. 2025; 63(1):141-155.
PMID: 39996512
PMC: 11864014.
DOI: 10.1080/13880209.2025.2469607.
Benacka R, Szaboova D, Gulasova Z, Hertelyova Z
Int J Mol Sci. 2025; 26(1.
PMID: 39795985
PMC: 11719911.
DOI: 10.3390/ijms26010127.
Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S
Front Oncol. 2025; 14:1499950.
PMID: 39744000
PMC: 11688480.
DOI: 10.3389/fonc.2024.1499950.
Tahtasakal R, Hamurcu Z, Oz A, Balli M, Dana H, Gok M
Ann Surg Oncol. 2024; 32(4):2994-3008.
PMID: 39692982
DOI: 10.1245/s10434-024-16656-0.
Rasool D, Jahani-Asl A
Transl Psychiatry. 2024; 14(1):462.
PMID: 39505843
PMC: 11541728.
DOI: 10.1038/s41398-024-03168-4.
Shedding Light on the Molecular Diversities of miRNA in Cancer- an Exquisite Mini Review.
Venkatesh S, Manaz P, Priya M, Ambiga G, Basu S
Mol Biotechnol. 2024; .
PMID: 39496855
DOI: 10.1007/s12033-024-01312-5.
Loss of miR-634 contributes to the formation FOXA1-positive triple negative breast cancer subtype.
Ren F, Rui X, Xiao X
Discov Oncol. 2024; 15(1):584.
PMID: 39441384
PMC: 11499465.
DOI: 10.1007/s12672-024-01472-5.
Suitability evaluation of toehold switch and EXPAR for cell-free MicroRNA biosensor development.
Copeland C, Kwon Y
Biotechnol Notes. 2024; 4:83-89.
PMID: 39416922
PMC: 11446392.
DOI: 10.1016/j.biotno.2023.11.003.
The Association of Neuroendocrine Differentiation with MicroRNA 21 and MicroRNA let7f Expression and the Clinicopathological Parameters in Primary Invasive Breast Carcinomas with Neuroendocrine Features.
Usul G, Kelten Talu E, Yilmaz I, Issin G, Bektas S, Trabulus D
Diagnostics (Basel). 2024; 14(19).
PMID: 39410615
PMC: 11475674.
DOI: 10.3390/diagnostics14192211.
Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.
Sebutsoe X, Tsotetsi N, Jantjies Z, Raphela-Choma P, Choene M, Motadi L
Onco Targets Ther. 2024; 17:785-801.
PMID: 39345275
PMC: 11439348.
DOI: 10.2147/OTT.S475132.
'Whole-Body' Perspectives of Schizophrenia and Related Psychotic Illness: miRNA-143 as an Exemplary Molecule Implicated across Multi-System Dysfunctions.
Waddington J, Wang X, Zhen X
Biomolecules. 2024; 14(9).
PMID: 39334950
PMC: 11430658.
DOI: 10.3390/biom14091185.
MiRNAs as potential biomarkers in early breast cancer detection: a systematic review.
Mihai A, Ianculescu L, Suciu N
J Med Life. 2024; 17(6):549-554.
PMID: 39296436
PMC: 11407494.
DOI: 10.25122/jml-2024-0322.
The mRNA and microRNA Landscape of the Blastema Niche in Regenerating Newt Limbs.
Zhang Q, Lu B
Int J Mol Sci. 2024; 25(17).
PMID: 39273174
PMC: 11395517.
DOI: 10.3390/ijms25179225.
Global-local aware Heterogeneous Graph Contrastive Learning for multifaceted association prediction in miRNA-gene-disease networks.
Si Y, Huang Z, Fang Z, Yuan Z, Huang Z, Li Y
Brief Bioinform. 2024; 25(5).
PMID: 39256197
PMC: 11387071.
DOI: 10.1093/bib/bbae443.
HHOMR: a hybrid high-order moment residual model for miRNA-disease association prediction.
Li Z, Wan L, Wang L, Wang W, Nie R
Brief Bioinform. 2024; 25(5).
PMID: 39175132
PMC: 11341279.
DOI: 10.1093/bib/bbae412.
The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance.
Zavesky L, Jandakova E, Weinberger V, Minar L, Kohoutova M, Tefr Faridova A
Oncology. 2024; 103(2):112-127.
PMID: 39134012
PMC: 11793102.
DOI: 10.1159/000540863.
MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications.
Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J
Front Cell Dev Biol. 2024; 12:1437951.
PMID: 39114567
PMC: 11304453.
DOI: 10.3389/fcell.2024.1437951.
MicroRNA-mediated metabolic regulation of immune cells in cancer: an updated review.
Khameneh S, Razi S, Lashanizadegan R, Akbari S, Sayaf M, Haghani K
Front Immunol. 2024; 15:1424909.
PMID: 39007129
PMC: 11239499.
DOI: 10.3389/fimmu.2024.1424909.
A label-free and rapid fluorometric strategy for microRNA detection using CRISPR-Cas12a coupled with copper nanoparticles.
Wang S, Wei Z, Li L, Luo Y, Huang Z, Yang X
Mikrochim Acta. 2024; 191(7):405.
PMID: 38896292
DOI: 10.1007/s00604-024-06496-w.
How MicroRNAs Command the Battle against Cancer.
Wu H, Leng S, Sergi C, Leng R
Int J Mol Sci. 2024; 25(11).
PMID: 38892054
PMC: 11172831.
DOI: 10.3390/ijms25115865.